# Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA

> **NCT06600698** · PHASE1,PHASE2 · RECRUITING · sponsor: **Milton S. Hershey Medical Center** · enrollment: 45 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** INM176

## Key facts

- **NCT ID:** NCT06600698
- **Lead sponsor:** Milton S. Hershey Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-05-07
- **Primary completion:** 2027-05-01
- **Final completion:** 2028-05-01
- **Target enrollment:** 45 (ESTIMATED)
- **Last updated:** 2026-04-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06600698

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06600698, "Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06600698. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*